Skip to content

PREVOR

Active
Private limited company (pre-2019)founded 201511 yrs activeRue des Chasseurs-Ardennais 3, 4031 Liège, BelgiumKBO/BCE: BE 0632.637.067
Summary

PREVOR has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.4m and a net result of €288,592. Equity is growing by ~38.9% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 0.8% (low).

Overview

Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE 21100Manufacture of basic pharmaceutical products and pharmaceutical preparations NACE 21201
#10 company by total assets in the province of Liège, Pharmaceuticals sector1 site
Size
€3.9mturnover 2025
Staff
19 FTE
Equity
€1.4m
Profit
€288,592
Financial health
68 Healthy Checked score 2025
Bankruptcy chance 12 m
0.8%
Structure
Parent
Prevor International · 100%
Holdings
1
Accounts filed 59 d late0 of 6 deeds read
Why 68- Latest accounts 59 days late; 3 of the last 3 late- Liquidity: current ratio 1.26, cash €154,182+ Founded in 2015+ Profit of €288,592 (FY 2025)Show the evidence

Checked score

Score 2025
68 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Better than 49% of its sector peers (NACE 21, small)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Strong
Solvency 61+7
equity 36.1% of total assets
Liquidity 43+1
short-term debt 29.9% · cash 4.1%
Profitability 82+1
return on assets 7.7%
Bankruptcy probability, 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%

About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.5% (43 companies)
Last 24 months 11-2024: 6.8% 12-2024: 6.8%● 0.0% vs 11-2024 01-2025: 6.7%▼ -1.7% vs 12-2024 02-2025: 2.9%▼ -56.2% vs 01-2025 03-2025: 3.3%▲ +13.6% vs 02-2025 04-2025: 3.8%▲ +14.0% vs 03-2025 05-2025: 6.0%▲ +57.3% vs 04-2025 06-2025: 6.0%▼ -0.1% vs 05-2025 07-2025: 6.7%▲ +12.8% vs 06-2025 08-2025: 8.7%▲ +29.1% vs 07-2025highest value 09-2025: 8.6%▼ -1.0% vs 08-2025 10-2025: 8.6%● 0.0% vs 09-2025 11-2025: 8.0%▼ -7.6% vs 10-2025 12-2025: 1.6%▼ -79.7% vs 11-2025 01-2026: 1.8%▲ +9.9% vs 12-2025 02-2026: 1.9%▲ +5.8% vs 01-2026 03-2026: 2.4%▲ +29.0% vs 02-2026 04-2026: 2.8%▲ +15.4% vs 03-2026 05-2026: 0.8%▼ -71.2% vs 04-2026 06-2026: 0.8%▼ -1.5% vs 05-2026 07-2026: 0.8%▼ -4.3% vs 06-2026 08-2026: 0.8%● 0.0% vs 07-2026 09-2026: 0.7%▼ -3.4% vs 08-2026lowest value 10-2026: 0.8%▲ +9.1% vs 09-2026
  • Latest accounts 59 days late; 3 of the last 3 late raises the probability
  • Liquidity: current ratio 1.26, cash €154,182 raises the probability
  • Founded in 2015 lowers the probability for this profile
  • Profit of €288,592 (FY 2025) lowers the probability
Credit up to €90,000 at 30 days acceptable
Liquidity tight (current ratio 1.26 against 1.02 in 2024; short-term debt: 29.9% and cash: 4.1% of total assets), and 63.9% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 21, small). Better than this share of them on solvency 26%, liquidity 35%, profitability 77%, growth against the median 59%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Latest accounts 59 days late; 3 of the last 3 late
In the bankruptcy model this factor raises the probability.
NBB · filings
raises risk · Liquidity: current ratio 1.26, cash €154,182
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
lowers risk · Founded in 2015
In the bankruptcy model this factor lowers the probability for this profile.
KBO
lowers risk · Profit of €288,592 (FY 2025)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
neutral · Filed after the deadline
The financial year that closed on 31-07-2025 was due by 28-02-2026 and was filed on 28-04-2026, 59 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
59 d late
2024
264 d late
2023
326 d late
2022
18 d early
2021
17 d late
2020
110 d late
2019
16 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 106 days after the deadline; the sector median for financial year 2024 is 9 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-07-2026 and is due by 28-02-2027. Nothing is late today. Usually files around 28 April (4 of the last 5 filed years within 205 days of that day).
Companies Code · seven months
Position in the running window
31-07-2026 close04-10-2026 today28-02-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · unclassified…
  2. Annual accounts filedfiscal year 2024 · unclassified…
  3. Highest result since 2019net €288,592 ▲8.8%

Key points

  • Positive: 6 years of growth in a rowturnover 2025: €3.9m 6 years View
  • Positive: Company by total assets in the province of…in the Checked rankings #10 View
  • Known shareholderslargest: Prevor International 100% 100% View
  • Positive: Equity rose in 2025from €1.1m to €1.4m ▲ 27.1% View

By topic

Financials

Fiscal year
2025
Turnover
€3.9m
Profit
€288,592
Solvency
36.1%
Turnover▲ 1.6%
Net result
20192025
Go to Financials

Timeline

Events
14
Since
2017
Next accounts
by 28-02-2027
  1. 28-04-2026Annual accounts filed
  2. 19-11-2025Annual accounts filed
  3. 31-07-2025Highest result since 2019
Go to Timeline

Company details

Sites
1
Legal form
Private limited company (pre-2019)
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21100
Founded
22-06-2015
Year ends
31-07
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.